Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000497251 | SCV000753519 | pathogenic | Neurofibromatosis, type 1 | 2022-05-28 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 431693). This sequence change creates a premature translational stop signal (p.Arg2562Aspfs*12) in the NF1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NF1 are known to be pathogenic (PMID: 10712197, 23913538). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with neurofibromatosis type 1 (NF1) (PMID: 15146469). This variant is also known as c.7682_7683delAG. For these reasons, this variant has been classified as Pathogenic. |
Ce |
RCV001171793 | SCV001334648 | pathogenic | not provided | 2020-03-01 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000497251 | SCV001479029 | pathogenic | Neurofibromatosis, type 1 | 2020-10-26 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000497251 | SCV002560587 | pathogenic | Neurofibromatosis, type 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Medical Genetics, |
RCV000497251 | SCV000588840 | pathogenic | Neurofibromatosis, type 1 | 2017-02-02 | no assertion criteria provided | clinical testing |